Joaquı́n Mateo
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 77
- Prostate Cancer Diagnosis and Treatment 16
- Oncology 69
- PARP inhibition in cancer therapy 42
- Co-authors
- Johann S. de Bono (68 shared papers)David Olmos (16 shared papers)Shahneen Sandhu (11 shared papers)Karim Fizazi (16 shared papers)Neal D. Shore (13 shared papers)Oliver Sartor (6 shared papers)Fred Saad (15 shared papers)Neeraj Agarwal (11 shared papers)
- Journals
- Journal of Clinical Oncology (44 papers)Annals of Oncology (16 papers)European Urology (9 papers)Clinical Cancer Research (4 papers)Cancer Research (3 papers)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Joaquı́n Mateo
143 papers receiving 5.7k citations
Joaquı́n Mateo's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.4k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 1.5k
- Radiology, Nuclear Medicine and Imaging 454
Countries citing papers authored by Joaquı́n Mateo
This map shows the geographic impact of Joaquı́n Mateo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joaquı́n Mateo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joaquı́n Mateo more than expected).
Fields of papers citing papers by Joaquı́n Mateo
This network shows the impact of papers produced by Joaquı́n Mateo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joaquı́n Mateo. The network helps show where Joaquı́n Mateo may publish in the future.
Co-authors
The 25 scholars most cited alongside Joaquı́n Mateo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 1460 |
| 2 | Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 489 |
| 3 | A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) Hit paper breakdown → | 2018 | 418 |
| 4 | 2012 | 272 | |
| 5 | Delivering precision oncology to patients with cancer Hit paper breakdown → | 2022 | 211 |
| 6 | 2016 | 165 | |
| 7 | 2014 | 160 | |
| 8 | 2015 | 122 | |
| 9 | 2016 | 113 | |
| 10 | 2018 | 112 | |
| 11 | 2016 | 106 | |
| 12 | 2016 | 81 | |
| 13 | 2002 | 76 | |
| 14 | 2018 | 74 | |
| 15 | 2013 | 72 | |
| 16 | 2019 | 67 | |
| 17 | 2022 | 66 | |
| 18 | 2021 | 63 | |
| 19 | 2022 | 61 | |
| 20 | 2015 | 58 |
About Joaquı́n Mateo
Joaquı́n Mateo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 149 papers that have together received 5.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (77 papers), PARP inhibition in cancer therapy (42 papers), Cancer Genomics and Diagnostics (27 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Cancer, Lipids, and Metabolism (10 papers), Bladder and Urothelial Cancer Treatments (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (2.7k citations), Molecular Biology (1.5k citations) and Radiology, Nuclear Medicine and Imaging (454 citations). Joaquı́n Mateo has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Johann S. de Bono, David Olmos, Shahneen Sandhu, Karim Fizazi, Neal D. Shore, Oliver Sartor, Fred Saad, Neeraj Agarwal, Antoine Thiery-Vuillemin and Carrie A. Adelman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Urology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.